Clinical and Epidemiological Characteristics of Vitiligo at Different Ages: An Analysis of 571 Patients in Northwest China

Objective: This study was performed to elucidate the clinical and epidemiological characteristics of vitiligo patients of different ages in Northwest China. Methods: We retrospectively reviewed the case records and questionnaires of all patients diagnosed with vitiligo, who visited People’s Hospital of Xinjiang Uygur Autonomous Region from May 2016 to December 2017. The clinical and epidemiological characteristics of these patients were analyzed by Pearson’s χ2 test and Fisher’s exact test. Results: In total, we collected data of 571 vitiligo patients with age of 32.9±16.4 years. The prevalence of segmental vitiligo in children and adolescents ≤19 years old (24/175[13.7%]) was higher than that in adults aged from 20-59 years (23/370[6.2%]) and advanced patients aged ≥60 years (1/26[3.8%]) (P=0.020). The prevalence of progressive vitiligo was higher in children and adolescents ≤19 years (72/175[41.1%]) and adults from 20–59 years (141/370[38.1%) than in patients ≥60 years (5/26[19.2%]) (P=0.063). Children and adolescents ≤19 years with vitiligo had a higher rate of a family history of vitiligo (20/175[11.4%]) than adults (20/370[5.4%]) and advanced age (1/26[3.8%]) (P=0.031). Conclusions: This study provides clinical evidence that vitiligo at different ages has different characteristics, mainly regarding an increased incidence of segmental vitiligo, a higher prevalence of atopic dermatitis and halo nevus, and a more common positive family history among children and adolescent patients. Key words: vitiligo; age grouping; epidemiology; prevalence

[1]  Stephanie A. Santorico,et al.  Genome-Wide Association of PVT1 with Vitiligo. , 2018, The Journal of investigative dermatology.

[2]  E. Odum,et al.  Frequency of thyroid dysfunctions among Nigerian patients with vitiligo , 2018 .

[3]  Xian-fa Tang,et al.  Vitiligo and autoimmune thyroid diseases , 2017 .

[4]  Haixia Shi Role of autophagy in the occurrence and development of vitiligo , 2017 .

[5]  T. Thng,et al.  Retrospective study on the characteristics and treatment of late-onset vitiligo , 2017, Indian journal of dermatology, venereology and leprology.

[6]  Jo Lambert,et al.  Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants , 2016, Nature Genetics.

[7]  T. McCormick,et al.  Current knowledge on psoriasis and autoimmune diseases , 2016, Psoriasis.

[8]  Hamad Ayed Alfahaad Clinico-epidemiological profile of vitiligo patients in Najran Region, Saudi Arabia , 2015 .

[9]  M. Hordinsky,et al.  Alopecia Areata: An Evidence-Based Treatment Update , 2014, American Journal of Clinical Dermatology.

[10]  L. Martins,et al.  A study of clinical profiles of vitiligo in different ages: an analysis of 669 outpatients , 2014, International journal of dermatology.

[11]  J. Lambert,et al.  Clinical profile of generalized vitiligo patients with associated autoimmune/autoinflammatory diseases , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

[12]  M. Picardo,et al.  Guidelines for the management of vitiligo: the European Dermatology Forum consensus , 2013, The British journal of dermatology.

[13]  T. Jouary,et al.  Pre‐ vs. post‐pubertal onset of vitiligo: multivariate analysis indicates atopic diathesis association in pre‐pubertal onset vitiligo , 2012, The British journal of dermatology.

[14]  A. Stratigos,et al.  Childhood- and later-onset vitiligo have diverse epidemiologic and clinical characteristics. , 2012, Journal of the American Academy of Dermatology.

[15]  J. Shapiro,et al.  Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. , 2010, Journal of the American Academy of Dermatology.

[16]  Rebat M Halder,et al.  Vitiligo update. , 2009, Seminars in cutaneous medicine and surgery.

[17]  U. Pajvani,et al.  The relationship between family medical history and childhood vitiligo. , 2006, Journal of the American Academy of Dermatology.

[18]  L. Montes,et al.  Vitiligo , 2002, The Lancet.